MIT chemists have uncovered a fascinating new insight into the role of cell membranes, challenging long-held beliefs about their function. The study, led by Professor Gabriela Schlau-Cohen, reveals that cell membranes are not just passive barriers but active participants in cellular processes, particularly in receptor dynamics and cancer cell proliferation.
The research focuses on the Epidermal Growth Factor Receptor (EGFR), a protein crucial for controlling cell growth. EGFR is often overexpressed in cancer cells, leading to uncontrolled growth. The study found that the composition of the cell membrane significantly influences EGFR function. When the membrane contains high levels of negatively charged lipids, EGFR becomes locked in an overactive state, promoting constant cell growth, even in the absence of the ligand EGF.
This discovery has profound implications for cancer treatment. By neutralizing the negative charge on the cell membrane, it may be possible to turn down EGFR signaling, offering a new avenue for tumor treatment. The research also highlights the role of cholesterol in membrane rigidity and its impact on EGFR signaling, providing further insights into membrane composition's complexity.
What makes this study particularly intriguing is the challenge it poses to the traditional view of cell membranes as mere scaffolds. As Schlau-Cohen notes, "The longstanding dogma of what a membrane does is that it's just a scaffold... However, there have been increasing observations that suggest that maybe these membrane lipids are actually playing a role in receptor function."
This research not only advances our understanding of cell membrane biology but also opens up exciting possibilities for cancer treatment. By manipulating membrane composition, scientists may be able to control receptor function, offering new hope for patients with cancer and other diseases influenced by receptor dynamics.
